|
货号 | 品名 | 规格 | 包装 | 单价 | 货期 | 库存 |
JD200512085706 | 群司珠单抗 | 99.30% | 5mg | 11000元 | 咨询客服 | 3天 |
JD200512085706 | 群司珠单抗 | 99.30% | 1mg | 3200元 | 咨询客服 | 3天 |
性状: | Trastuzumab 是一种人源化单克隆抗体,其以高亲和力与 HER2 选择性结合。Trastuzumab 已被批准用于治疗 HER2 阳性转移性乳腺癌和 HER2 阳性胃癌。 |
质量标准: | Molecular Weight 145145.09 SMILES [Trastuzumab] Storage Please store the product under the recommended conditions in the Certificate of Analysis. References [1]. Sliwkowski MX, et al. Nonclinical studies addressing the mechanism of action of trastuzumab. Semin Oncol. 1999 Aug;26(4 Suppl 12):60-70. [2]. Hudis CA, et al. Trastuzumab--mechanism of action and use in clinical practice. N Engl J Med. 2007 Jul 5;357(1):39-51. [3]. Barok M, et al. Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance. Mol Cancer Ther. 2007 Jul;6(7):2065-72. |